Phase 1 × Bortezomib × Classical hematology × Clear all
NCT03878524 2024-03-04

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

OHSU Knight Cancer Institute

Phase 1 Terminated
2 enrolled
NCT00006098 2013-06-18

PS-341 in Treating Patients With Hematologic Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Completed